Clinical Trials Directory

Trials / Completed

CompletedNCT02236273

Interactive, Health Literacy Promoting Text Messages and HPV Vaccine Completion In Minority Adolescents

Comparative Effectiveness of Interactive, Health Literacy Promoting Text Messages on HPV Vaccine Completion In Minority Adolescents

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
956 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Emerging communication technologies, such as text messaging offer low-cost, scalable opportunities to improve health literacy and promote healthy behaviors, such as vaccination. While the investigators reported the success of text message vaccine reminders, effects were limited by their untailored approach. The trans-theoretical model of behavior change supports tailoring interventions to an individual's stage of decision-making. Human papillomavirus (HPV) is the most prevalent sexually transmitted virus in the U.S. and can lead to genital warts, and cervical, anal and penile cancer. The three-dose vaccine is 90-100% efficacious. Minorities are at greatest risk for such cancers but have low HPV vaccine completion rates. Limited health literacy regarding the vaccine can affect series completion. The investigators will compare the effects of enhancing text message vaccination reminders with interactive, vaccine health literacy-promoting information tailored to vaccine decision making-stage on HPV vaccine series completion. The effects of these messages represent a new paradigm in interactive health communications.

Conditions

Interventions

TypeNameDescription
BEHAVIORALConventional text message reminderReceipt of conventional text message notifying when due for next dose
BEHAVIORALEnhanced text message remindersReceipt of enhanced text messages notifying when due for next dose coupled with educational information

Timeline

Start date
2014-12-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-09-10
Last updated
2025-07-29
Results posted
2025-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02236273. Inclusion in this directory is not an endorsement.